IOVA Stock Catalyst: Iovance Biotherapeutics Reported Record Second Quarter 2026 Revenue

Aug 6, 2026 · 7:01am ET

Company announced financial results for the period.

Max move

+49.3%

High of day $6.39

Sparker timei

7:01am ET

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Iovance Biotherapeutics, Inc. announced on Second Quarter 2026 Iovance Biotherapeutics reported record second quarter 2026 revenue.

The announcement cited ~$99M.

IOVANCE BIOTHERAPEUTICS, INC. has a free float of 387,874,054 shares and 446,502,396 shares outstanding.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time IOVA sparks.

Catch the next IOVA-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.